Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Johnson & Johnson (NY:JNJ)

224.44 +2.95 (+1.33%)

Official Closing Price Updated: 4:10 PM EST, Jan 27, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	8,153,959
Open	222.00
Bid (Size)	224.11 (500)
Ask (Size)	225.00 (100)
Prev. Close	221.49
Today's Range	220.70 - 225.50
52wk Range	141.50 - 222.17
Shares Outstanding	2,628,679,824
Dividend Yield	2.32%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

JNJ Stock Rises On Fresh FDA Approval For Multiple Myeloma Drug ↗

Today 16:25 EST

FDA approved Darzalex Faspro in combination with bortezomib, lenalidomide, and dexamethasone for adults with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant.

Via Stocktwits

The $14.5 Billion Clot-Bust: Boston Scientific’s Bold Bet on Penumbra Signals a New Era of Medtech Giants

Today 14:31 EST

In a move that has sent shockwaves through the healthcare sector, Boston Scientific Corporation (NYSE: BSX) announced on January 15, 2026, its definitive agreement to acquire Penumbra, Inc. (NYSE: PEN)...

Via MarketMinute

Performance

YTD	+8.2%	+8.2%
1 Month	+8.1%	+8.1%
3 Month	+17.9%	+17.9%
6 Month	+35.0%	+35.0%
1 Year	+46.8%	+46.8%

More News

The $100 Billion Milestone: Johnson & Johnson Pivots from 'Steady' 2025 to Growth-Focused 2026

Today 11:57 EST

Via MarketMinute

Johnson & Johnson Marks $100 Million of MedTech Products Donated Since 2020 to Help People Live, See and Smile

Today 8:00 EST

From Johnson & Johnson

Via Business Wire

The Great Consolidation: US M&A Values Double as AI and Bio-Pharma Spark $2 Trillion Surge

January 26, 2026

Via MarketMinute

Johnson & Johnson At 52‑Week High: Momentum, Fundamentals And An Earnings Window ↗

January 26, 2026

Via Talk Markets

Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors ↗

January 25, 2026

Via MarketBeat

2 Under-the-Radar Biotech Stocks Set to Boom in 2026 ↗

January 24, 2026

Via The Motley Fool

Johnson & Johnson 2026 Outlook: Chasing the $100 Billion Milestone Amidst Legal and Patent Hurdles

January 23, 2026

Via MarketMinute

2 Soaring Stocks to Hold for the Next 20 Years ↗

January 23, 2026

Via The Motley Fool

The Software Surge: How 2024’s $25.7 Billion M&A Explosion in Diagnostics Redefined Healthcare

January 23, 2026

Via MarketMinute

Johnson & Johnson Quietly Triggers a Trend Following Buy Signal ↗

January 23, 2026

Via MarketBeat

Stability Meets Scale: Why Johnson & Johnson is Poised for a Breakout 2026

January 23, 2026

Via MarketMinute

Is This Dividend King a Screaming Buy? ↗

January 23, 2026

Via The Motley Fool

The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market

January 22, 2026

Via MarketMinute

I Correctly Predicted That These 15 Dow Jones Stocks Would Boost Their Payouts in 2025. Here's Why It Can Happen Again in 2026. ↗

January 22, 2026

Via The Motley Fool

Resilience in the Face of the Patent Cliff: Johnson & Johnson Forecasts Landmark 2026 Growth

January 22, 2026

Via MarketMinute

Johnson & Johnson Analyst Raises Price Target On Several Tailwinds In 2026 ↗

January 22, 2026

Via Benzinga

The Davos Pivot: Trump’s Tariff U-Turn Sends Markets Into a Greenland Glow ↗

January 22, 2026

Via Chartmill

This 2.4%-Yielding Dividend King Remains As Healthy As Ever ↗

January 22, 2026

Via The Motley Fool

S&P 500 Jumps Over 1% As Trump Withdraws EU Tariff Threat: Investor Sentiment Improves, Fear & Greed Index Remains In 'Neutral' Zone ↗

January 22, 2026

Via Benzinga

Is This Dividend King Stock a Buy After a Major Development? ↗

January 21, 2026

Via The Motley Fool

J&J Forecasts $100 Billion Milestone for 2026 as Trump Drug Pricing Deals Reshape the Pharma Landscape

January 21, 2026

Via MarketMinute

Johnson & Johnson (JNJ) Earnings Call Transcript ↗

January 21, 2026

Via The Motley Fool

Discover the top S&P500 movers in Wednesday's pre-market session. ↗

January 21, 2026

Via Chartmill

Frequently Asked Questions

Is Johnson & Johnson publicly traded?

Yes, Johnson & Johnson is publicly traded.

What exchange does Johnson & Johnson trade on?

Johnson & Johnson trades on the New York Stock Exchange

What is the ticker symbol for Johnson & Johnson?

The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange

What is the current price of Johnson & Johnson?

The current price of Johnson & Johnson is 224.44

When was Johnson & Johnson last traded?

The last trade of Johnson & Johnson was at 01/27/26 04:10 PM ET

What is the market capitalization of Johnson & Johnson?

The market capitalization of Johnson & Johnson is 589.98B

How many shares of Johnson & Johnson are outstanding?

Johnson & Johnson has 590B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.